Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.

Leukemia & lymphoma - 1 Sept 2014

Huang Pauline Y, Best Oliver G, Almazi Juhura G, Belov Larissa, Davis Zadie A, Majid Aneela, Dyer Martin J, Pascovici Dana, Mulligan Stephen P, Christopherson Richard I

Abstract excerpt

Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent disease for many years, 20-30% will progress and ultimately die of their disease. CLL may be classified by the Rai or Binet staging system, mutational status of the immunoglobulin variable heavy-chain gene (IGVH), ZAP-70 overexpression, cytogenetic abnormalities (13q-, + 12, 11q-, 17p-) and expression of several cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to B-Lymphocytes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cluster Analysis

Share to Disease Progression

Share to Immunophenotyping

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Prognosis

Share to Reproducibility of Results

Source

Identifiers

PMID: 24289109
DOI: 10.3109/10428194.2013.867486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.PMID 24289109Read ↗

CD Markers and HLA Expression in Chronic Lymphocytic Leukemia Patients: correlations and clinical relevanceSemantic proximity Read ↗

Morphological and Immunophenotypic Features of Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemiaSemantic proximity Read ↗

Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.Semantic proximity Read ↗

Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphoma.Semantic proximity Read ↗

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B‐cell chronic lymphocytic leukemiaSemantic proximity Read ↗

Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional PerspectiveSemantic proximity Read ↗

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.Semantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.Semantic proximity Read ↗

Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.Semantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.